Stockreport

Axsome's (AXSM) Narcolepsy Drug Study Meets Primary Goal [Yahoo! Finance]

Axsome Therapeutics, Inc.  (AXSM) 
Last axsome therapeutics, inc. earnings: 3/12 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: axsome.com
PDF The study achieved its primary endpoint of a rapid and significant reduction in weekly cataplexy events. Data from the study showed that treatment with AXS-12 reduced [Read more]